Skip to content

Financial Navigation Program for Improving Financial Toxicity Among Breast Cancer in China

Evaluation of the Financial Navigation Program for Improving Financial Toxicity Among Breast Cancer in China

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06484140
Enrollment
82
Registered
2024-07-03
Start date
2024-06-17
Completion date
2024-11-17
Last updated
2025-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Neoplasm Female, Financial Navigation, Financial Toxicity

Brief summary

The goal of this study is to access the impact of a financial navigation program on improving financial toxicity among patients with breast cancer in China. The main questions it aims to answer are: * Does the intervention alleviate participants' financial toxicity? * Does the intervention enhance participants' cost-related health literacy? * Does the intervention improve participants' shared decision-making? * Does the intervention reduce participants' perceived stress? Researchers will compare the financial navigation program with usual oncology care to evaluate its effectiveness. Participants will receive the comprehensive financial navigation, including: * Needs assessment; * Cost-related health education, mainly including topics regarding communication of cost, treatment-related cost, health insurance policies, and family support; * Resource and service referral; * Personalized counseling.

Interventions

During hospitalization, participants will receive needs assessment, and one-on-one cost-related health education with a material booklet. Resource and service referral will be delivered face-to-face or by phone when the navigator identifies unaddressed problems. Within three months after discharge, participants will receive monthly follow-up phone calls and personalized counseling via WeChat.

OTHERUsual Care

Participants will receive usual oncology care during hospitalization and regular follow-up after discharge. Participants have the freedom to utilize any financial resources, but financial navigators do not offer comprehensive information support.

Sponsors

Fudan University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Newly diagnosed with breast cancer and undergoing surgery during this admission; * Female, age 18 years or older; * Receiving or expected to receive one or more of the following therapies: chemotherapy, radiotherapy, endocrine therapy, targeted therapy, and immunotherapy; * Eastern Cooperative Oncology Group Performance Status 0-2; * Provided informed consent to participate in this study.

Exclusion criteria

* Diagnosed with ductal carcinoma in situ (DCIS) * Presence of any serious psychiatric disorders; * Cognitive impairments; * Difficulty in reading, writing, or communicating in Chinese.

Design outcomes

Primary

MeasureTime frameDescription
Financial toxicityBaseline, 1st month and 3rd month since baselineFinancial toxicity will be measured with the Comprehensive Score for Financial Toxicity-Functional Assessment of Chronic Illness Therapy Version 2 (COST-FACIT-V2); lower scores (range, 0-44) indicating greater financial toxicity.
Material domain of financial toxicity1st month and 3rd month since baselineMaterial domain of financial toxicity will be measured with 2 items adapted from the Medical Expenditure Panel Survey (MEPS).
Behavioral domain of financial toxicity1st month and 3rd month since baselineBehavioral domain of financial toxicity will be measured by employment changes and cost-related nonadherence with 6 items adapted from MEPS and previous literature.

Secondary

MeasureTime frameDescription
Cost-related health literacyBaseline, 1st month and 3rd month since baselineThe cost-related health literacy will be measured with homemade 10-item questionnaire, with higher scores indicating higher cost-related health literacy.
Shared decision-makingBaseline, 1st month and 3rd month since baselineThe shared decision-making ability will be measured with 9-item shared decision-making questionnaire (SDM-Q-9); higher scores (range, 0-45) indicating a greater degree of participants' involvement in shared decision-making.
Perceived stressBaseline, 1st month and 3rd month since baselineThe perceived stress will be measured with Perceived Stress Scale (PSS); higher scores (range, 0-56) indicating greater perceived stress.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 29, 2026